Study of tilrekimig for severe asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled with current treatments. It aims to see if tilrekimig can reduce asthma attacks and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had severe asthma for at least 12 months.
- You've had at least 2 asthma attacks in the last year that needed steroids or a hospital visit.
- Your asthma medication includes a medium-to-high dose inhaled steroid plus another controller medicine (like a long-acting bronchodilator) for the past year.
- You are not currently taking oral steroids or certain biologic treatments for asthma.
- You do not have other lung diseases like COPD, pulmonary fibrosis, or cystic fibrosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.
This trial tests a new drug called tozorakimab for adults whose asthma is not well controlled despite using medium-to-high dose inhaled steroids. The study aims to find the best dose and see if it reduces asthma attacks.
This trial tests a new medicine called AK139 for people with asthma. It aims to see if the drug is safe and helps control asthma symptoms better than current treatments.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.